Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Daly

Showing results (101-110 of 472) with videos related to

Pageof 48
Sort By:
The Journal of Bone and Joint Surgery. British Volume|May 1, 1996
The prognosis for walking in osteogenesis imperfectaK Daly, A Wisbeach, I Sanpera, et al.
DNA and Cell Biology|January 7, 2020
Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-AmoxiclavMohammad A Alshabeeb, Guruprasad P Aithal, Ann K Daly
Genome Biology and Evolution|July 27, 2013
In silico resurrection of the major vault protein suggests it is ancestral in modern eukaryotesToni K Daly, Andrew J Sutherland-Smith, David Penny
The Biochemical Journal|May 1, 1989
Differential expression of the alpha and beta retinoic acid receptors in tissues of the ratJ L Rees, A K Daly, C P Redfern
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 27, 2002
Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy?Ann K Daly, Christopher P Day, Peter T Donaldson
British Journal of Clinical Pharmacology|July 25, 2000
CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card systemG A Ford, S M Wood, A K Daly
Biochimica Et Biophysica Acta|August 16, 2011
Genetic modifiers of non-alcoholic fatty liver disease progressionQuentin M Anstee, Ann K Daly, Christopher P Day
Seminars in Liver Disease|May 4, 2011
Genetics of alcoholic and nonalcoholic fatty liver diseaseQuentin M Anstee, Ann K Daly, Christopher P Day
Journal of Enzyme Inhibition|January 1, 1986
Kinetic studies on the major form of aldehyde reductase in ox kidney: a general kinetic mechanism to explain substrate-dependent mechanisms and the inhibition by anticonvulsantsD M Worrall, A K Daly, T J Mantle
Drug Metabolism Reviews|May 21, 1999
Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issuesD W Nebert, M Ingelman-Sundberg, A K Daly
Pageof 48

Showing results (101-110 of 472) with videos related to

Sort By:
Pageof 48
The Journal of Bone and Joint Surgery. British Volume|May 1, 1996
The prognosis for walking in osteogenesis imperfectaK Daly, A Wisbeach, I Sanpera, et al.
DNA and Cell Biology|January 7, 2020
Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-AmoxiclavMohammad A Alshabeeb, Guruprasad P Aithal, Ann K Daly
Genome Biology and Evolution|July 27, 2013
In silico resurrection of the major vault protein suggests it is ancestral in modern eukaryotesToni K Daly, Andrew J Sutherland-Smith, David Penny
The Biochemical Journal|May 1, 1989
Differential expression of the alpha and beta retinoic acid receptors in tissues of the ratJ L Rees, A K Daly, C P Redfern
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 27, 2002
Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy?Ann K Daly, Christopher P Day, Peter T Donaldson
British Journal of Clinical Pharmacology|July 25, 2000
CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card systemG A Ford, S M Wood, A K Daly
Biochimica Et Biophysica Acta|August 16, 2011
Genetic modifiers of non-alcoholic fatty liver disease progressionQuentin M Anstee, Ann K Daly, Christopher P Day
Seminars in Liver Disease|May 4, 2011
Genetics of alcoholic and nonalcoholic fatty liver diseaseQuentin M Anstee, Ann K Daly, Christopher P Day
Journal of Enzyme Inhibition|January 1, 1986
Kinetic studies on the major form of aldehyde reductase in ox kidney: a general kinetic mechanism to explain substrate-dependent mechanisms and the inhibition by anticonvulsantsD M Worrall, A K Daly, T J Mantle
Drug Metabolism Reviews|May 21, 1999
Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issuesD W Nebert, M Ingelman-Sundberg, A K Daly
Pageof 48